Background: For non-ST elevation acute coronary syndrome (NSTE ACS), guidelines
endorse an invasive strategy, but the optimal timing (immediate, early, or delayed) is
debated, especially for emergency department (ED) pathways. We aimed to synthesize
studies comparing early versus delayed invasive management in NSTE ACS, focusing on
clinically relevant outcomes overall and within risk strata. Method: MEDLINE, PubMed,
Embase, Cochrane CENTRAL, Web of Science, and Scopus (inception to 2025);
ClinicalTrials.gov, WHO ICTRP; reference lists and forward citation tracking. Dual
independent screening, data extraction with a piloted form, and PRISMA-aligned
reporting. Risk of bias was assessed with RoB 2 (trials) and ROBINS I (cohorts). Owing to
heterogeneity in timing cut-offs, therapies, and endpoints, a structured qualitative
synthesis was performed. Results: In trials, routine immediate invasive management did
not reduce major clinical events versus delayed approaches in unselected patients.
Signals consistently favored earlier angiography among high-risk subgroups,
particularly GRACE scores more than 140 and those with heart failure, while an isolated
trial showed the benefit of immediate intervention. Observational data aligned with
neutral overall effects but associated earlier procedures (within 24 to 48 h) with
improved outcomes in higher risk patients. Major bleeding and procedural
complications were generally similar between timing strategies. Conclusions: For ED
care, a risk tailored approach is supported: immediate invasive management for very
high risk features; early (less than 24 h) for high risk patients; and angiography within 24
to 72 h appears safe for stabilized intermediate risk patients.
Keywords: NSTE ACS; early invasive strategy; delayed invasive strategy; coronary
angiography; percutaneous coronary intervention; time to treatment; risk stratification;
GRACE risk score; emergency department; systematic review
